Camillo Golgi Awardees:

2024 Madrid
R. Pop-Busui (US): It’s complicated: using lessons from the past and the knowledge of the present to build a future free of diabetes complications

2023 Hamburg
S. Herzig (DE): Diabetes complications: from classical to emerging

2022 Stockholm
M. Horowitz (AU): Gastric emptying in diabetes - backwards and forwards: a perspective from the antipodes

2021 Virtual Meeting
H.L. Heerspink (NL): Personalising the treatment for patients with type 2 diabetes: the mean is meaningless

2020 Virtual Meeting
N. Sattar (UK): Cardiovascular risks in diabetes: new insights from simple observations

2019 Barcelona
R.A. Malik (QA): Diabetic neuropathy: a time to challenge the dogma

2018 Berlin

P.P. Nawroth (DE): Diabetic complications: an alternative view on diabetes

2017 Lisbon
B.M. Frier (UK): Recurrent hypoglycaemia in diabetes: the long-term complications

2016 Munich
P. Rossing (DK): Personalising prevention of diabetic nephropathy, from proteinuria to profile-omics

2015 Stockholm
H.-P. Hammes (DE): The eye in diabetes: a personal account

2014 Vienna
S. Tesfaye (UK): Diabetic neuropathy: a journey with tears, passion, new insights and paradigm shift

2013 Barcelona
T. Lauritzen (DK): A journey from insulin absorption to screening for type 2 diabetes

2012 Berlin
G. Pugliese (IT): Galectin-3: only a stooge of RAGE?

2011 Lisbon
A. Bierhaus (DE): Failure of glucose lowering in clinical trials: the way to novel biochemical concepts explaining diabetic late complications

2010 Stockholm
D. Ziegler (DE): Diabetic neuropathy: the winding road from early detection to timely protection

2009 Vienna
P.-H. Groop (FI): Diabetic nephropathy - means, motive and opportunity

2008 Rome
A. Avogaro (IT): From damage to progenitors: the harsh days of endothelium in diabetes

2007 Amsterdam
P. Fioretto (IT): The kidney in diabetes: Dynamic pathways of injury and repair

2006 Copenhagen
M. Laakso (FI): Pathogenesis of cardiovascular disease in type 2 diabetes: Role of insulin resistance and hyperglycaemia

2005 Athens
C. Stehouwer (NL): The many faces of cvascular dysfunction in diabetes

2004 Munich
A. Ceriello (IT): Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes and cardiovascular disease? The "common soil" hypothesis revisited

2003 Paris
A. Boulton (UK): The diabetic foot: From art to science

2002 Budapest
J. Tuomiletho (FI): Prediction and prevention of type 2 diabetes - epidode 2

2001 Glasgow
A. Flyvbjerg (DK): Potential therapeutic strategies in diabetic kidney disease

2000 Jerusalem
U. Di Mario (IT): From hyperglycaemia to the dysregulation of vascular remodelling in diabetes

1999 Brussels
E. Standl (DE): The diabetic "Sweet" heart: From ailing to failing

1998 Barcelona
D.R. Tomlinson (UK): A common aetiology for diabetes complications

1997 Helsinki
H.-H. Parving (DK): Renoprotection in diabetes: Genetic and non-genetic risk factors and treatment

1996 Vienna
M.-R. Taskinen (FI): New insights into pathophysiology of dyslipidaemia in NIDDM

1995 Stockholm
R. Landgraf (DE): The impact of pancreatic grafting on secondary complications and quality of life

1994 Düsseldorf
J.E. Tooke (UK): Microvascular function in diabetes mellitus

1993 Istanbul
K.F. Hansen (NO): Blood glucose control - does it always matter? Research from glycosylated haemoglobin to renal morphology

1992 Prague
E. Kohner (UK): Blood flow changes in diabetes: What do they mean?

1991 Dublin
R. Osterby (DK): Renal Microstructures related to renal function in diabetes

1990 Copenhagen
P.J. Watkins (UK): Clinical observations and experiments in diabetic nephropathy

1989 Lisbon
G.B. Bolli (IT): From physiology of counter-regulation to prevention of hypoglycaemia in insulin-dependent diabetes mellitus

1988 Paris
C.E. Morgensen (DK): Hyper-filtration, hypertension and diabetic nephropathy

1987 Leipzig
D.J. Ewing (UK): New horizons for diabetic autonomic neuropathy

1986 Rome
G.C. Viberti (UK): Preventive strategies in diabetic kidney disease